Sagnelli Evangelista, Sagnelli Caterina, Pisaturo Mariantonietta, Coppola Nicola
Evangelista Sagnelli, Mariantonietta Pisaturo, Nicola Coppola, Section of Infectious Diseases, Department of Mental Health and Public Medicine, Second University of Naples, 80131 Naples, Italy.
World J Gastroenterol. 2014 Jun 14;20(22):6707-15. doi: 10.3748/wjg.v20.i22.6707.
The hepatitis C virus (HCV) causes an acute infection that is frequently asymptomatic, but a spontaneous eradication of HCV infection occurs only in one-third of patients. The remaining two-thirds develop a chronic infection that, in most cases, shows an indolent course and a slow progression to the more advanced stages of the illness. Nearly a quarter of cases with chronic hepatitis C (CHC) develop liver cirrhosis with or without hepatocellular carcinoma. The indolent course of the illness may be troubled by the occurrence of a hepatic flare, i.e., a spontaneous acute exacerbation of CHC due to changes in the immune response, immunosuppression and subsequent restoration, and is characterized by an increase in serum aminotransferase values, a frequent deterioration in liver fibrosis and necroinflammation but also a high frequency of sustained viral response to pegylated interferon plus ribavirin treatment. A substantial increase in serum aminotransferase values during the clinical course of CHC may also be a consequence of a superinfection by other hepatotropic viruses, namely hepatitis B virus (HBV), HBV plus hepatitis D virus, hepatitis E virus, cytomegalovirus, particularly in geographical areas with high endemicity levels. The etiology of a hepatic flare in patients with CHC should always be defined to optimize follow-up procedures and clinical and therapeutic decisions.
丙型肝炎病毒(HCV)可引发急性感染,这种感染通常没有症状,但只有三分之一的患者能够自发清除HCV感染。其余三分之二则会发展为慢性感染,在大多数情况下,病程进展缓慢,逐渐发展到疾病的更晚期。近四分之一的慢性丙型肝炎(CHC)病例会发展为肝硬化,伴或不伴有肝细胞癌。疾病的缓慢进程可能会因肝内炎症发作而受到干扰,即由于免疫反应变化、免疫抑制及随后的恢复导致CHC自发急性加重,其特征是血清转氨酶值升高、肝纤维化和坏死性炎症频繁恶化,但对聚乙二醇干扰素加利巴韦林治疗出现持续病毒学应答的频率也很高。在CHC临床病程中血清转氨酶值大幅升高也可能是其他嗜肝病毒重叠感染的结果,即乙型肝炎病毒(HBV)、HBV加丁型肝炎病毒、戊型肝炎病毒、巨细胞病毒,特别是在地方性流行程度高的地理区域。应始终明确CHC患者肝内炎症发作的病因,以优化随访程序以及临床和治疗决策。